DGCR5 is highly selectively expressed in ccRCC tissues, and at the same time, its expression level in ccRCC is quite high, which is one of the main reasons that we decided to further investigate its clinical use as a tumor biomarker. This evidence concerns the gene DGCR5 and nonpapillary renal cell carcinoma.